Anticoagulation and platelet activation in hemodialysis: clinical results with PMMA.
作者信息
Coli L, Cianciolo G, Feliciangeli G, De Sanctis L B, Zanchelli F, Dalmastri V, De Pascalis A, Sestigiani E, Donati G, Stefoni S
机构信息
St. Orsola University Hospital, Bologna, Italy.
出版信息
Contrib Nephrol. 1999;125:111-9. doi: 10.1159/000059954.
PMID:9895435
Abstract
摘要
相似文献
1
Anticoagulation and platelet activation in hemodialysis: clinical results with PMMA.血液透析中的抗凝与血小板活化：聚甲基丙烯酸甲酯的临床结果
Contrib Nephrol. 1999;125:111-9. doi: 10.1159/000059954.
2
Platelet and leucocyte behaviour during haemodialysis.
Contrib Nephrol. 1999;125:120-32. doi: 10.1159/000059955.
3
Comparison of the effects of cellulose triacetate and polysulfone membrane on GPIIb/IIIa and platelet activation.三醋酸纤维素和聚砜膜对血小板糖蛋白IIb/IIIa及血小板活化作用的比较。
Blood Purif. 2003;21(2):176-82. doi: 10.1159/000069157.
4
Heparin is unable to prevent contact activation by three different membranes.
Proc Eur Dial Transplant Assoc. 1981;18:269-74.
5
Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis.普通肝素与低分子量肝素：血液透析的中期比较
Nephron. 2002;92(3):589-600. doi: 10.1159/000064086.
6
Clinical evaluation of three haemodialysers containing PMMA membranes of different surface area, with special attention to thrombogenicity.
Nephrol Dial Transplant. 1991;6 Suppl 2:43-8.
7
Effect of a new anticoagulant (MD 805) on platelet activation in the hemodialysis circuit.
Thromb Res. 1986 Jan 1;41(1):33-41. doi: 10.1016/0049-3848(86)90277-x.
8
[Criteria of the biocompatibility of the membranes used in dialysis].
Minerva Nefrol. 1981 Apr-Jun;28(2):109-11.
9
High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results.
Contrib Nephrol. 1999;125:96-110. doi: 10.1159/000059953.
10
Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach.血液透析过程中血小板与中性粒细胞的相互作用：一种提出的生物相容性方法。
Int J Artif Organs. 1998 Feb;21(2):75-82.
Zotero 插件